Press Releases
AxoGen Announces RECON® Study Update
AxoGen, Inc. Pre-Announces Financial and Operational Results
AxoGen Appoints Christopher Crisman as Vice President, U.S. Sales
AxoGen Announces Avance® Nerve Graft Recipient Selected to Ride on Donate Life Rose Parade® Float
AxoGen Advances its Platform for Nerve Repair at Annual Analyst and Investor Day
AxoGen to Host Third Annual Analyst and Investor Day on November 19, 2018
AxoGen, Inc. Reports 2018 Third Quarter Financial Results
Avance® Nerve Graft Receives Regenerative Medicine Advanced Therapy (RMAT) Designation
AxoGen, Inc. to Report Third Quarter 2018 Financial Results and Host Conference Call on October 29, 2018
AxoGen, Inc. to Present at the Cantor Fitzgerald Global Healthcare Conference
